Conference Recap
Conference Recap
Follicular Lymphoma Highlights From ASH 2022
Follicular lymphoma highlights from ASH 2022 include a comparison of rituximab to watch-and-wait and updates on tazemetostat and mosunetuzumab, as...
Conference Recap
Chronic Lymphocytic Leukemia Highlights From ASH 2022
CLL treatments from ASH 2022 include pirtobrutinib in pretreated patients, zanubrutinib in relapsed/refractory disease, and frontline ibrutinib +...
AVAHO 2022: A Multidisciplinary Approach to Self-care in Cancer Care
AVAHO 2022: The Necessity of Self-care in Cancer Care
AVAHO 2022: An Opportunity to Recharge
AVAHO 2022: A Boost of Confidence
AVAHO 2022: The Importance of Self-care
AVAHO 2022: Bringing Provider Well-Being Into Focus
Conference Recap
Non-Hodgkin Lymphoma Updates From ASH 2021
Highlights in non-Hodgkin lymphoma that were presented at ASH 2021...
Conference Recap
Highlights in Non–Small Cell Lung Cancer From ASCO 2020
Dr. Mark Kris reports on key studies in NSCLC from ASCO 2020, including the practice-changing ADAURA trial, results on an antibody‒...